FDA Inspection 986030 — USC Reproductive Endocrinology and Infertility

USC Reproductive Endocrinology and Infertility — FEI 3004715781

The FDA completed an inspection of USC Reproductive Endocrinology and Infertility on June 15, 2016 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 15, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Los Angeles, CA (United States)